Industry

Biotechnology

Funding needs

HKD 300 million for new manufacturing facilities, 3 IND applications of FDA & NMPA (i.e. foot ulcer drug pre-clinical trials and phase 1 clinical trial), R&D, and intellectual properties applications

Geographic locations

Hong Kong-based company with a 5,000 sq.ft GMP Pharmaceutical Grade Research and Manufacturing Center and a 1000 sq. ft R&D laboratory in the Hong Kong Science Park
Planned commercialization of Recombinant protein large-scale production technology